CVS Health Corporation CVS
Set alert
88.51 USD -1.74 -1.93%
At close · Nov 2
88.56 +0.05 +0.06%
After hours · Nov 2, 5:55 PM ET
87.88 Day range 90.62
69.51 52-week range 110.68
- YTD
- +11.53%
- 1 year
- +13.26%
- Open
- 91.95
- Prev close
- 90.25
- Mkt cap
- 113.20B
- Vol
- 9.55M
- Avg vol
- 7.96M
- EPS
- 3.80
- P/E
- 23.29
- Div yield
- 2.95%
More statistics
- Low
- 87.88
- High
- 90.62
- Forward P/E
- 10.37
- Beta
- 0.58
- Short ratio
- 1.63
- Inst. own
- 90.99%
- Dividend
- 2.66
- Ex-div date
- Oct 21, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 91.23
- 200-d avg
- 88.79
- 1y target
- 115.48
3M chart
Events in this range
- Aug 5, 2026Earnings: 2.58; estimate 1.85; surprise 39.46%
- Aug 6, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Aug 6, 2026Rating: UBS · Buy → Buy
- Aug 12, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 19, 2026Rating: Argus Research · Buy → Buy
- Sep 3, 2026Rating: UBS · Buy → Buy
- Oct 12, 2026Rating: Leerink Partners · Outperform → Outperform
- Oct 22, 2026Dividend: 0.665
Signals (13)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 8 hours ago |
| MACD: Sell Signal | Oct 30, 2026 | 3 days ago |
| SMA: Bearish | Oct 27, 2026 | 6 days ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 31, 2026 | 2 months ago |
| RSI: Oversold | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
Financial health
Altman Z-Score
2.45 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 5
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 1
- P/E 2
- P/B 4
Valuation
P/E 56.7×
FY 2016 5y median 17.2× FY 2025
P/S 0.3×
FY 2016 5y median 0.3× FY 2025
P/B 1.3×
FY 2016 5y median 1.3× FY 2025
P/FCF 12.9×
FY 2016 5y median 9.1× FY 2025
EV/EBITDA 18.8×
FY 2016 5y median 11.6× FY 2025
EV/Sales 0.5×
FY 2016 5y median 0.5× FY 2025
FCF Yield 7.8%
FY 2016 5y median 11.0% FY 2025
Profitability
Gross Margin 13.8%
FY 2016 5y median 15.2% FY 2025
Operating Margin 2.6%
FY 2016 5y median 2.6% FY 2025
Net Margin 0.4%
FY 2016 5y median 1.3% FY 2025
ROE 2.4%
FY 2016 5y median 6.1% FY 2025
ROIC 4.7%
FY 2016 5y median 4.7% FY 2025
ROA 0.7%
FY 2016 5y median 1.9% FY 2025
Growth (YoY)
Revenue 7.8%
FY 2016 FY 2025
Operating Income 21.9%
FY 2016 FY 2025
EPS (diluted) -62.0%
FY 2016 FY 2025
Free Cash Flow 23.4%
FY 2016 FY 2025
Financial Health
Current Ratio 0.8×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 0.6×
FY 2016 5y median 0.6× FY 2025
Debt / Equity 1.2×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 8.6×
FY 2016 5y median 4.7× FY 2025
Interest Coverage 3.3×
FY 2016 5y median 3.5× FY 2025
Dividends
Dividend Yield 3.4%
FY 2016 5y median 3.1% FY 2025
Payout Ratio 192.1%
FY 2016 5y median 67.4% FY 2025
Annual · latest fiscal year ends 2025-12-31